Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest
b"What juicy perks do biotech startups offer to lure increasingly hard-to-find talent? How does Sanofi plan to make up for lost time in the lucrative field of oncology? And veteran biotech journalist Luke Timmerman talks about what it's like to climb Mt. Everest."